Published in Trans Am Clin Climatol Assoc on January 01, 1998
Congenital neutropenia: diagnosis, molecular bases and patient management. Orphanet J Rare Dis (2011) 1.66
Toward a universal treatment for cancer: cell inflation assisted chemotherapy. Cancer Med (2013) 0.77
The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes. J Biol Chem (1959) 17.39
Iodination of bacteria: a bactericidal mechanism. J Exp Med (1967) 10.30
The growth of mouse bone marrow cells in vitro. Aust J Exp Biol Med Sci (1966) 9.68
Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med (1966) 7.30
Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med (1991) 6.33
Factors regulating macrophage production and growth. Purification and some properties of the colony stimulating factor from medium conditioned by mouse L cells. J Biol Chem (1977) 4.63
In vitro control of the development of macrophage and granulocyte colonies. Proc Natl Acad Sci U S A (1966) 4.13
Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet (1992) 3.76
Purification and properties of colony-stimulating factor from mouse lung-conditioned medium. J Biol Chem (1977) 3.74
Leukokinetic studies. IV. The total blood, circulating and marginal granulocyte pools and the granulocyte turnover rate in normal subjects. J Clin Invest (1961) 3.63
Structure and function of leukocyte integrins. Immunol Rev (1990) 3.62
Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J Exp Med (1996) 2.39
A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood (1993) 2.29
Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet (1988) 2.28
Effects of purified bacterially synthesized murine multi-CSF (IL-3) on hematopoiesis in normal adult mice. Blood (1986) 2.26
Hemopoietic responses in mice injected with purified recombinant murine GM-CSF. Exp Hematol (1987) 2.25
Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood (1988) 2.24
Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Eur J Cancer (1993) 2.08
Filgrastim (r-metHuG-CSF): the first 10 years. Blood (1996) 1.99
Review: granulocyte colony-stimulating factor--role and relationships in infectious diseases. J Infect Dis (1995) 1.77
Randomised placebo-controlled trial of granulocyte-colony stimulating factor in diabetic foot infection. Lancet (1997) 1.77
Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans. Blood (1996) 1.72
Colony stimulating factor and the regulation of granulopoiesis and macrophage production. Fed Proc (1975) 1.68
Bone marrow colony stimulating activity in human sera. Results of two independent surveys in Buffalo and Melbourne. Br J Haematol (1968) 1.56
Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet (1989) 1.54
Effect of endotoxin on serum granulocyte and granulocyte-macrophage colony-stimulating factor levels in dogs. J Infect Dis (1992) 1.49
The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood (1993) 1.36
Accelerated neutrophil apoptosis in the acquired immunodeficiency syndrome. J Clin Invest (1996) 1.30
Quantitative studies on the stimulation of mouse bone marrow colony growth in vitro by normal human urine. Aust J Exp Biol Med Sci (1969) 1.17
Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium. J Clin Invest (1988) 1.07
Characterization of a serum factor stimulating the differentiation of myelomonocytic leukemic cells. Int J Cancer (1980) 1.06
Purification of a multipotential colony-stimulating factor from pokeweed mitogen-stimulated mouse spleen cell conditioned medium. J Biol Chem (1985) 1.03
The colony stimulating factors. Discovery, development, and clinical applications. Cancer (1990) 1.02
Cyclic urinary leukopoietic activity in gray collie dogs. Science (1971) 1.00
Pathophysiology and treatment of severe chronic neutropenia. Ann Hematol (1996) 0.98
The control of growth and differentiation in normal and leukemic blood cells. Cancer (1990) 0.94
Changes in granulocyte colony-stimulating factor concentration in patients with trauma and sepsis. J Trauma (1996) 0.91
Renewed interest in granulocyte transfusion therapy. Br J Haematol (1997) 0.85
Time to resolution of morbidity: an endpoint for assessing the clinical cure of community-acquired pneumonia. Respir Med (1996) 0.84
The role of the colony-stimulating factors in resistance to acute infections. Immunol Cell Biol (1987) 0.84
Chronic neutropenia. A new canine model induced by human granulocyte colony-stimulating factor. J Clin Invest (1991) 0.80
Differential alterations in plasma colony-stimulating factor concentrations in meningococcaemia. Clin Exp Immunol (1995) 0.78